Revolution Medicines, Inc. RVMD Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $987.33M+66.6% | $592.8M+40.1% | $423.14M+67.2% | $253.07M+35.4% | ||
| $195.04M+102% | $96.72M+27.9% | $75.62M+86.3% | $40.59M+33.3% | ||
| $1.18B+71.5% | $689.52M+38.2% | $498.77M+69.8% | $293.66M+35.1% | ||
| -$1.18B-71.5% | -$689.52M-41.5% | -$487.19M-88.6% | -$258.28M-37.4% | ||
| $24.23M— | —— | $0— | $0-100% | ||
| $54.33M-38.7% | $88.68M+87.5% | $47.29M+417% | $9.15M+898% | ||
| -$1.13B-88.3% | -$600.85M-36.6% | -$439.89M-76.6% | -$249.13M-33.2% | ||
| -$1.13B-88.5% | -$600.09M-37.5% | -$436.37M-75.5% | -$248.71M-32.9% | ||
| -$5.94-65.9% | -$3.58+6.8% | -$3.84-24.7% | -$3.08-19.8% | ||
| -$1.17B-72.0% | -$682.97M-41.6% | -$482.24M-89.6% | -$254.31M-37.5% | ||
| -$1.18B-71.5% | -$689.52M-41.5% | -$487.19M-88.6% | -$258.28M-37.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Is Revolution Medicines, Inc. profitable?
- Revolution Medicines, Inc. is not currently profitable: it reported a net loss of $1.4B over the trailing twelve months, a -76423.3% net margin.
- What is Revolution Medicines, Inc.'s earnings per share?
- Revolution Medicines, Inc.'s diluted EPS over the trailing twelve months is $-7.10.
- Where does Revolution Medicines, Inc.'s income statement data come from?
- Every line is extracted from Revolution Medicines, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.